A61K 49/0041
Xanthene dyes, used in vivo
Official title: {Xanthene dyes, used in vivo, e.g. administered to a mice, e.g. rhodamines, rose Bengal (in vivo G01N)}
A61K49/0041 (Xanthene dyes, used in vivo) appears on 704 US grants and 1,130 published applications in this corpus.
Search patents in A61K- Granted patents
- 704
- Published applications
- 1,130
- Assignees
- 560
- Inventors
- 2,336
- Latest grant
- 1 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 2 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 3 | 0 |
| 1990 | 1 | 0 |
| 1991 | 3 | 0 |
| 1992 | 3 | 0 |
| 1993 | 2 | 0 |
| 1994 | 2 | 0 |
| 1995 | 1 | 0 |
| 1996 | 2 | 0 |
| 1997 | 2 | 0 |
| 1998 | 9 | 0 |
| 1999 | 8 | 0 |
| 2000 | 6 | 0 |
| 2001 | 15 | 4 |
| 2002 | 13 | 18 |
| 2003 | 8 | 22 |
| 2004 | 6 | 22 |
| 2005 | 8 | 33 |
| 2006 | 12 | 26 |
| 2007 | 8 | 42 |
| 2008 | 14 | 34 |
| 2009 | 10 | 51 |
| 2010 | 14 | 55 |
| 2011 | 27 | 68 |
| 2012 | 40 | 34 |
| 2013 | 35 | 57 |
| 2014 | 38 | 55 |
| 2015 | 39 | 43 |
| 2016 | 31 | 41 |
| 2017 | 36 | 72 |
| 2018 | 26 | 61 |
| 2019 | 49 | 49 |
| 2020 | 44 | 67 |
| 2021 | 40 | 69 |
| 2022 | 39 | 53 |
| 2023 | 31 | 51 |
| 2024 | 27 | 46 |
| 2025 | 31 | 32 |
| 2026 | 18 | 25 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Method for treating cancerous tissue with a nanotherapeutic1 Sep 2026US 12,721,910 B2Imam Abdulrahman Bin Faisal University
- Methods for preparing nanotherapeutic compositions1 Sep 2026US 12,721,911 B2Imam Abdulrahman Bin Faisal University
- Functionalized silica nanorings, methods of making same, and uses thereof11 Aug 2026US 12,703,637 B2Cornell University
- Detection of colonic neoplasia in vivo using near-infrared peptide targeted against overexpressed cMet4 Aug 2026US 12,697,402 B2The Regents of the University of Michigan
- Methods of applying preparations of dyes and hydrogels to a tissue26 May 2026US 12,636,383 B2
- Fluorescein-labeled nerve targeting peptide formulations and related methods8 Oct 2026US 2026/0306676 A1Alume Biosciences, Inc.
- Liposome Composition Comprising Farnesol and Method of Use Thereof for Treating Fungal Infection24 Sep 2026US 2026/0283957 A1
- Synthetic estrogen receptor (er)-derived peptide17 Sep 2026US 2026/0274922 A1The Texas A&M University System
- Bi-specific adapters and their use with universal car-t cells in the treatment of caix-expressing tumors10 Sep 2026US 2026/0263643 A1Purdue Research Foundation
- Peptide inhibitors of focal adhesion kinase activity and uses thereof10 Sep 2026US 2026/0265304 A1Arizona Board of Regents on Behalf of the University of Arizona
Most cited
By later US patents
- Method and device for detecting and quantifying glucose in body fluids905US 5,342,789 ASensor Technologies, Inc. · 1994
- SMMR (small molecule metabolite reporters) for use as in vivo glucose biosensors891US 8,008,088 B2Masimo Laboratories, Inc. · 2011
- Non-invasive measurement of analytes836US 8,509,867 B2Cercacor Laboratories, Inc. · 2013
- SMMR (small molecule metabolite reporters) for use as in vivo glucose biosensors707US 8,029,765 B2Masimo Laboratories, Inc. · 2011
- SMMR (small molecule metabolite reporters) for use as in vivo glucose biosensors651US 8,466,286 B2Cercacor Laboratories, Inc. · 2013